Aviva’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-118,930
Closed -$7.77M 911
2026
Q1
$7.77M Buy
118,930
+1,596
+1% +$119K 0.01% 563
2025
Q4
$9.3M Buy
117,334
+6,616
+6% +$507K 0.02% 557
2025
Q3
$8.08M Buy
110,718
+7,266
+7% +$533K 0.01% 566
2025
Q2
$7.85M Buy
103,452
+6,545
+7% +$463K 0.02% 557
2025
Q1
$7.37M Buy
96,907
+14,054
+17% +$1.05M 0.02% 501
2024
Q4
$5.47M Sell
82,853
-12,300
-13% -$861K 0.01% 527
2024
Q3
$6.63M Sell
95,153
-3,372
-3% -$203K 0.02% 455
2024
Q2
$5.21M Buy
+98,525
New +$5.98M 0.01% 499

Other funds holding SOLV

Aviva's SOLV Position: Q2 2026 in Review

Aviva sold out of Solventum (SOLV) in Q2 2026, closing a stake of 118,930 shares — an estimated $7.77M sold.

Aviva first reported a position in SOLV in Q2 2024 and held it in 8 quarters. The position peaked at $9.3M in Q4 2025. 878 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • Aviva reported no remaining Solventum position as of Q2 2026 after selling out during the quarter.
  • Aviva sold 118,930 Solventum shares in Q2 2026, an estimated $7.77M.
  • Aviva first reported a position in Solventum in Q2 2024 and held it in 8 quarters.
  • Aviva's Solventum position peaked at $9.3M in Q4 2025.
  • 878 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.